Phreesia, a leader in patient intake, outreach and activation, has been selected by The Software Report as one of the “Top 100 Software Companies of 2024.” The annual program evaluates companies based on a range of criteria, including product functionality, customer satisfaction, corporate reputation, innovative capabilities, organizational depth, ESG involvement and long-term viability. This is the third consecutive year Phreesia has been named to the list.

“We are proud once again to be recognized as a leader in SaaS innovation,” said Phreesia CEO Chaim Indig. “This honor reflects Phreesia’s dedication to investing in products that help drive better health outcomes. We remain committed to making care easier every day and transforming the healthcare experience for both patients and providers.”

In the announcement, The Software Report describes its list of honored companies as those that “are making a major impact on the software industry” in 2024. Phreesia is ranked 11 out of the 100 companies, up four spots from 2023. Other awardees this year include Hootsuite, Celigo and Enable.

For more information on Phreesia, visit www.phreesia.com.

About Phreesia Phreesia is the trusted leader in patient activation, giving providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 150 million patient visits in 2023—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Media Contact: Nicole Gist nicole.gist@phreesia.com 407-760-6274

Phreesia (NYSE:PHR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Phreesia.
Phreesia (NYSE:PHR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Phreesia.